RPE65 and intrahepatic cholangiocarcinoma: Previously, it has been reported that some RPE65 missense variants (c.200T>G and c.430T>C), with no predicted effect in splicing, lead to a reduction in the expression of the mRNA of RPE65 and barely detectable levels of the RPE65 protein in ICC [46].